RNS ARCHIVES

To receive RNS announcements and updates as they are issued please contact medaphor@walbrookpr.com

MedaPhor’s AI obstetric image database exceeds 1 million images

MedaPhor (AIM:MED), the intelligent ultrasound software and simulation company, is pleased to announce that its database used for training its artificial intelligence (AI) products now exceeds 1 million obstetric ultrasound images. Large image libraries are a prerequisite to creating AI solutions. These images have helped MedaPhor to develop its ScanNav® AI-based clinical software for ultrasound professionals. The one million mark is a significant milestone for the Company, as it will enable it to build on its ScanNav software for the global obstetric ultrasound market. MedaPhor’s ScanNav intelligent ultrasound technology, which uses AI algorithms and deep learning techniques to automatically assess [...]

November 27th, 2018|

Placing an open offer and notice of General Meeting [26/11/18]

MedaPhor (AIM: MED), the intelligent ultrasound software and simulation company, announces that it is proposing to raise £5.0 million (before the deduction of fees and expenses) through the conditional issue of 58,823,530 Placing Shares at 8.5 pence per Ordinary Share. In addition, the Company is proposing to raise up to a further £2.1 million approximately (before the deduction of fees and expenses) through an Open Offer via the issue of up to 24,219,354 Open Offer Shares at 8.5 pence per Ordinary Share. The New Ordinary Shares will rank, pari passu, in all other respects with the Company's Existing Ordinary Shares. Read full [...]

November 26th, 2018|

MedaPhor commences clinical trial for AnatomyGuide

MedaPhor (AIM:MED), the intelligent ultrasound software and simulation company, announces it is commencing a clinical trial within the Aneurin Bevan University Health Board to capture data for its AnatomyGuide artificial intelligence (AI) software for ultrasound-guided anaesthetic procedures such as peripheral nerve blocks. Increasingly, ultrasound-guided peripheral nerve blocks are being used as a safer and more cost-effective alternative to general anaesthesia but not all anaesthetists have the specialist knowledge of ultrasound anatomy to perform them. AnatomyGuide provides software support and guidance to aid less experienced clinicians during the procedure. Using deep-learning techniques on a data set of thousands of real-patient images, the [...]

November 23rd, 2018|

Medaphor recognised as top 10 AI solution provider 2018

MedaPhor has been named in Education Technology Insight magazine’s list of  Top 10 Artificial Intelligence Solution Providers 2018. The magazine is one of the United States’ leading publications for those with an interest in how technology adoption can transform educational delivery. MedaPhor’s real-time ultrasound image analysis software, ScanNav, uses deep learning-based algorithms to automatically identify, grade and capture good ultrasound images to provide real-time guidance, assessment and audit of obstetric scanning. In an interview with the magazine the company’s Chief Technology Officer, Nick Sleep, explained how ScanNav has the potential to revolutionise the clinical practise of ultrasound. To read full [...]

November 14th, 2018|

MedaPhor provides quality control of fetal ultrasound images for the HAPIN trial

MedaPhor (AIM: MED), the intelligent ultrasound software and simulation company, announces it is working with the Household Air Pollution Intervention Network (HAPIN) trial to provide quality control of fetal ultrasound images. The work is led by principal investigators at Johns Hopkins, Emory and Colorado State Universities and is funded by The Bill & Melinda Gates Foundation and the National Institutes for Health (NIH). The HAPIN study, currently taking place in Guatemala, India, Peru and Rwanda, is a randomised controlled trial to assess the effect of using of liquefied petroleum gas (LPG) stoves instead of customary cooking practices on air pollution, child [...]

November 13th, 2018|

MedaPhor assists the INTERGROWTH-21st Project at the University of Oxford  

MedaPhor, the intelligent ultrasound software and simulation company, has provided valuable assistance to The International Fetal and Newborn Growth (INTERGROWTH-21st) Consortium led by the University of Oxford. The Consortium has developed new international standards describing optimal fetal and newborn growth, which are being incorporated into clinical care around the world to improve health outcomes. The INTERGROWTH-21st Project involved collecting data throughout pregnancy, including over 500,000 fetal ultrasound images, from healthy women in eight geographically diverse regions of the world. To classify the anatomical structures in those images automatically, the Consortium applied MedaPhor’s ScanNav® intelligent ultrasound technology, which uses AI algorithms and [...]

November 9th, 2018|

Director/PDMR Shareholding

Further to the announcement made on 8 October 2018, MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces that Andrew Barker, Non-Executive Director of the Company, has been issued 66,781 new ordinary shares of 1 pence each in the capital of the Company (“Ordinary Shares”) pursuant to the completion of the acquisition of Intelligent Ultrasound Limited, which was originally announced on 19 September 2017. Following this issue, Mr. Barker has an interest in 200,344 Ordinary Shares representing approximately 0.2 per cent. of the Company's issued ordinary share capital. Full announcement is available here. Enquiries: investors.medaphor.com/advisors 

October 9th, 2018|

Payment of deferred consideration

On 6 October 2017, MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announced completion of the acquisition of Intelligent Ultrasound Limited ("IUL") (the “Acquisition”) pursuant to a sale and purchase agreement (the “IUL SPA”).  In accordance with the terms of the IUL SPA, 6,175,975 new ordinary shares of 1p each in the Company (“Ordinary Shares”) (“the Retention Shares”) and a new warrant certificate representing rights to subscribe for 418,897 new Ordinary Shares (“the Retention Warrants”) are being issued to the vendors of IUL (“Vendors”). The issue of the Retention Shares and the Retention Warrants was, under the [...]

October 8th, 2018|

MedaPhor featured in The Silicon Review’s 30 Fastest Growing Tech Companies 2018

MedaPhor Group plc has been named as one of the 30 Fastest Growing Tech Companies 2018 by US business magazine, The Silicon Review. To mark the listing, the magazine has published an exclusive interview with MedaPhor’s CEO Stuart Gall, who discusses the company’s business divisions, gold-standard product portfolio and his vision for the future of ultrasound. We’re in a highly competitive market, but we have always set ourselves the target of being recognized as the gold standard in terms of product performance. The full interview is available to read here.  […]

September 11th, 2018|